Nautilus Biotechnology to Announce Third Quarter 2022 Financial Results on November 1, 2022
October 05 2022 - 08:00AM
GlobeNewswire Inc.
Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a
company pioneering a single-molecule protein analysis platform for
quantifying the proteome, today announced it will report financial
results for the third quarter 2022 before market open on Tuesday,
November 1, 2022.
The company’s management will webcast a corresponding conference
call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time
to discuss its results, business developments, and outlook. Live
audio of the webcast will be available on the “Investors” section
of the company website at: www.nautilus.bio.
About Nautilus Biotechnology, Inc.With its
corporate headquarters in Seattle and its research and development
headquarters in the San Francisco Bay Area, Nautilus is a
development stage life sciences company creating a platform
technology for quantifying and unlocking the complexity of the
proteome. Nautilus’ mission is to transform the field of proteomics
by democratizing access to the proteome and enabling fundamental
advancements across human health and medicine. To learn more about
Nautilus, visit www.nautilus.bio.
Media Contactpress@nautilus.bio
Investor
Contactinvestorrelations@nautilus.bio
Nautilus Biotechnology (NASDAQ:NAUT)
Historical Stock Chart
From May 2023 to Jun 2023
Nautilus Biotechnology (NASDAQ:NAUT)
Historical Stock Chart
From Jun 2022 to Jun 2023